Vantive US Healthcare LLC

Vantive is an independent healthcare company specializing in vital organ therapies, with a 70-year legacy in kidney care products and services. The company develops and markets dialysis equipment, continuous renal replacement therapy (CRRT) systems, and extracorporeal carbon dioxide removal (ECCO2R) technology for acute care settings. Vantive's product portfolio includes peritoneal dialysis systems such as HomeChoice, hemodialysis platforms, and advanced therapies like PrismaLung+ for ARDS management. The company serves chronic kidney disease patients and acute care settings through three integrated pillars: therapies (innovative medical devices for kidney and organ support), digital solutions (software platforms to optimize care quality and efficiency), and advanced services and education (clinician training and patient support programs). Vantive operates across home-based therapies, in-center dialysis, and acute care markets. The company emphasizes coordinated care ecosystems and patient-centric treatment options including home dialysis modalities. Manufacturing and R&D capabilities support clinical research and regulatory submissions. Vantive prioritizes evidence-based innovation with publications in peer-reviewed journals and presentations at major nephrology conferences. The organization serves patients, caregivers, and clinical teams with comprehensive support resources and medical information services.